ConductScience.org, home

Trial · NCT03412513

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in the total score of Overactive Bladder Symptom Scale(OABSS)Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the total score of Overactive Bladder Symptom Scale(OABSS) from baseline(Visit 2) to Visit 4
SecondaryChange in the total score of OABSS(Overactive Bladder Symptom Scale)Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the total score of OABSS, Visit 3, Visit 4 and Visit 5
SecondaryChange in the total score of IPSS(International Prostate Symptom Score)Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the total score of IPSS and bothersome score, Visit 3, Visit 4 and Visit 5
SecondaryChange in the total score of OAB-q short formBaseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the total score of OAB-q short form,Visit 3, Visit 4 and Visit 5
SecondaryChange in the total score of PPBC(Patient Perception of Bladder Condition)Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the total score of PPBC, Visit 3, Visit 4 and Visit 5
SecondaryChange in the total score of TSQ (Treatment Satisfaction Questionnaire)Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the total score of TSQ, Visit 3, Visit 4 and Visit 5
SecondaryChange in the total score of GRA (Global Response Assessment)Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the total score of GRA, Visit 3, Visit 4 and Visit 5
SecondaryChange in the score of BSW (Benefit, Satisfaction and Willingness to Continue Questions)Baseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the score of BSW, Visit 4 and Visit 5
SecondaryChange in the Mean Frequent UrinationBaseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the Mean Frequent Urination, Visit 3 and Visit 4
SecondaryChange in the Mean number of Urinary urgencyBaseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the Mean number of Urinary urgency, Visit 3 and Visit 4
SecondaryChange in the Mean number of Urinary incontinenceBaseline(Visit 2 : 0 week), Visit 3(3-5 weeks post Visit 2), Visit 4(6-10 weeks post Visit 2), Visit 5(10-14 weeks post Visit 2)Change in the Mean number of Urinary incontinence, Visit 3 and Visit 4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03412513/registered